Andrew J. Murphy

2.1k total citations
100 papers, 890 citations indexed

About

Andrew J. Murphy is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Andrew J. Murphy has authored 100 papers receiving a total of 890 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Pulmonary and Respiratory Medicine, 37 papers in Surgery and 35 papers in Molecular Biology. Recurrent topics in Andrew J. Murphy's work include Renal and related cancers (26 papers), Renal cell carcinoma treatment (16 papers) and Neuroblastoma Research and Treatments (8 papers). Andrew J. Murphy is often cited by papers focused on Renal and related cancers (26 papers), Renal cell carcinoma treatment (16 papers) and Neuroblastoma Research and Treatments (8 papers). Andrew J. Murphy collaborates with scholars based in United States, United Kingdom and Canada. Andrew J. Murphy's co-authors include Andrew M. Davidoff, Harold N. Lovvorn, Abdelhafeez H. Abdelhafeez, Janene Pierce, Lindsay J. Talbot, Jason Axt, Tristan Knight, Teresa Santiago, Sara A. Mansfield and Mark P. de Caestecker and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Andrew J. Murphy

88 papers receiving 879 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew J. Murphy United States 18 348 325 319 147 111 100 890
Jennifer H. Aldrink United States 18 412 1.2× 316 1.0× 256 0.8× 202 1.4× 189 1.7× 113 1.1k
Pascale Philippe‐Chomette France 20 452 1.3× 226 0.7× 296 0.9× 116 0.8× 116 1.0× 48 934
Marcus M. Malek United States 17 476 1.4× 193 0.6× 217 0.7× 86 0.6× 108 1.0× 55 839
Anita P. Price United States 20 500 1.4× 238 0.7× 698 2.2× 153 1.0× 219 2.0× 67 1.4k
Michael Robinette Canada 18 322 0.9× 328 1.0× 608 1.9× 66 0.4× 114 1.0× 34 1.1k
Maria Debora De Pasquale Italy 17 419 1.2× 143 0.4× 140 0.4× 118 0.8× 160 1.4× 76 829
Eliana Maria Monteiro Caran Brazil 13 377 1.1× 126 0.4× 173 0.5× 82 0.6× 80 0.7× 48 732
Sandra Viero Canada 16 173 0.5× 121 0.4× 232 0.7× 373 2.5× 91 0.8× 27 894
Peter Vorwerk Germany 23 361 1.0× 404 1.2× 148 0.5× 174 1.2× 200 1.8× 53 1.3k
C. Dicks-Mireaux United Kingdom 18 352 1.0× 233 0.7× 244 0.8× 108 0.7× 181 1.6× 35 983

Countries citing papers authored by Andrew J. Murphy

Since Specialization
Citations

This map shows the geographic impact of Andrew J. Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew J. Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew J. Murphy more than expected).

Fields of papers citing papers by Andrew J. Murphy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew J. Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew J. Murphy. The network helps show where Andrew J. Murphy may publish in the future.

Co-authorship network of co-authors of Andrew J. Murphy

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew J. Murphy. A scholar is included among the top collaborators of Andrew J. Murphy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew J. Murphy. Andrew J. Murphy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Jun, Andrew M. Davidoff, & Andrew J. Murphy. (2025). From preneoplastic lesion to heterogenous tumor: recent insights into hepatoblastoma biology and therapeutic opportunities. Molecular Cancer. 24(1). 198–198. 2 indexed citations
2.
3.
Sutton, Kathryn S., Amy L. Walz, Andrew J. Murphy, et al.. (2025). Remaining Challenges in the Treatment of Relapsed Wilms Tumor: Children's Oncology Group and International Society of Paediatric Oncology Perspectives. Pediatric Blood & Cancer. 72(8). e31790–e31790.
4.
Pio, Luca, Allison F. O’Neill, Helen Woodley, et al.. (2025). Hepatoblastoma. Nature Reviews Disease Primers. 11(1). 36–36. 5 indexed citations
5.
Murphy, Andrew J., Jack Brzezinski, Lindsay A. Renfro, et al.. (2024). Long‐term outcomes and patterns of relapse in patients with bilateral Wilms tumor or bilaterally predisposed unilateral Wilms tumor, a report from the COG AREN0534 study. International Journal of Cancer. 155(10). 1824–1831. 3 indexed citations
6.
Glick, Richard D., Rodrigo Romao, Max Pachl, et al.. (2024). Current surgical approaches to pediatric renal tumors. Pediatric Blood & Cancer. 72(S2). e31118–e31118. 2 indexed citations
7.
Fleming, Andrew M., Danny Yakoub, Nosratollah Nezakatgoo, et al.. (2024). CTNNB1 exon 3 mutations in metastatic solid pseudopapillary neoplasm of the pancreas. Journal of Surgical Oncology. 130(5). 1051–1061. 1 indexed citations
8.
Mansfield, Sara A., Meera Kotagal, Andrew J. Murphy, et al.. (2024). Enhanced Recovery After Surgery for Pediatric Abdominal Tumor Resections: A Prospective Multi-institution Study. Journal of Pediatric Surgery. 60(2). 162046–162046. 3 indexed citations
9.
10.
Guyer, Richard A., Jessica L. Mueller, Andrew J. Murphy, et al.. (2023). Differentiated neuroblastoma cells remain epigenetically poised for de-differentiation to an immature state. Disease Models & Mechanisms. 16(12). 2 indexed citations
11.
Fleming, Andrew M., Hyea Jin Gil, Andrew S. Boghossian, et al.. (2023). Oncogenic Cells of Renal Embryonic Lineage Sensitive to the Small-Molecule Inhibitor QC6352 Display Depletion of KDM4 Levels and Disruption of Ribosome Biogenesis. Molecular Cancer Therapeutics. 23(4). 478–491. 1 indexed citations
12.
Fleming, Andrew M., Zachary E. Stiles, Paxton V. Dickson, et al.. (2023). Lymph node metastases in young patients with gastrointestinal stromal tumor: A nationwide analysis. Journal of Surgical Oncology. 128(8). 1268–1277.
13.
Mothi, Suraj Sarvode, Luca Pio, Motomi Mori, et al.. (2023). Feasibility of indocyanine green‐guided localization of pulmonary nodules in children with solid tumors. Pediatric Blood & Cancer. 70(10). e30437–e30437. 11 indexed citations
14.
Gil, Hyea Jin, Emília M. Pinto, Andrew M. Fleming, et al.. (2022). TERT Expression in Wilms Tumor Is Regulated by Promoter Mutation or Hypermethylation, WT1, and N-MYC. Cancers. 14(7). 1655–1655. 3 indexed citations
15.
16.
Jin, Hongjian, Beisi Xu, Shivendra V. Singh, et al.. (2021). KDM6B promotes activation of the oncogenic CDK4/6-pRB-E2F pathway by maintaining enhancer activity in MYCN-amplified neuroblastoma. Nature Communications. 12(1). 7204–7204. 31 indexed citations
17.
Dieffenbach, Bryan V., Nan Li, Arin L. Madenci, et al.. (2020). Incidence of and risk factors for late cholecystectomy in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. European Journal of Cancer. 133. 4–13. 3 indexed citations
18.
Madenci, Arin L., Bryan V. Dieffenbach, Qi Liu, et al.. (2019). Late‐onset anorectal disease and psychosocial impact in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. Cancer. 125(21). 3873–3881. 5 indexed citations
19.
Knight, Tristan, et al.. (2019). Current Management of Pleuropulmonary Blastoma: A Surgical Perspective. Children. 6(8). 86–86. 27 indexed citations
20.
Murphy, Andrew J., et al.. (1995). Adult-onset congenital erythropoietic porphyria (Günther's disease) presenting with thrombocytopenia.. PubMed. 88(6). 357P–358P. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jennifer H. Aldrink Breakdown of academic impact, for papers by Pascale Philippe‐Chomette Breakdown of academic impact, for papers by Marcus M. Malek Breakdown of academic impact, for papers by Anita P. Price Breakdown of academic impact, for papers by Michael Robinette Breakdown of academic impact, for papers by Maria Debora De Pasquale Breakdown of academic impact, for papers by Eliana Maria Monteiro Caran Breakdown of academic impact, for papers by Sandra Viero Breakdown of academic impact, for papers by Peter Vorwerk Breakdown of academic impact, for papers by C. Dicks-Mireaux
Rankless by CCL
2026